Head-to-head comparison of 2 inflammatory biomarkers for the long-term prediction of left ventricular diastolic dysfunction in type 2 diabetes patients: Soluble ST2 versus hs-CRP
- 1 July 2014
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (3) , 811-812
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Serum triglycerides and risk of cardiovascular diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- High-Sensitive C-Reactive Protein: Universal Prognostic and Causative Biomarker in Heart Disease?Biomarkers in Medicine, 2012
- Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatmentHeart Failure Reviews, 2011
- Toll/Interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunctionCardiovascular Diabetology, 2011
- Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart FailureJACC, 2008